BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

543 related articles for article (PubMed ID: 17448142)

  • 21. Aggressive, multifocal oral verrucous leukoplakia: proliferative verrucous leukoplakia or not?
    Ghazali N; Bakri MM; Zain RB
    J Oral Pathol Med; 2003 Aug; 32(7):383-92. PubMed ID: 12846784
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Proliferative verrucous leukoplakia: an elusive disorder.
    Parashar P
    J Evid Based Dent Pract; 2014 Jun; 14 Suppl():147-53.e1. PubMed ID: 24929599
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Proliferative verrucous leukoplakia and its related lesions.
    Batsakis JG; Suarez P; el-Naggar AK
    Oral Oncol; 1999 Jul; 35(4):354-9. PubMed ID: 10645398
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Frequent alterations of p16INK4a and p14ARF in oral proliferative verrucous leukoplakia.
    Kresty LA; Mallery SR; Knobloch TJ; Li J; Lloyd M; Casto BC; Weghorst CM
    Cancer Epidemiol Biomarkers Prev; 2008 Nov; 17(11):3179-87. PubMed ID: 18990760
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inherited proliferative oral disorder: a reductionist approach to proliferative verrucous leukoplakia.
    Radhakrishnan R
    Indian J Dent Res; 2011; 22(3):365-6. PubMed ID: 22048571
    [No Abstract]   [Full Text] [Related]  

  • 26. [Proliferative verrucous leukoplakia. Report of five cases].
    Reichart PA; Philipsen HP
    Mund Kiefer Gesichtschir; 2003 May; 7(3):164-70. PubMed ID: 12764683
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Oral squamous cell carcinoma associated with proliferative verrucous leukoplakia compared with conventional squamous cell carcinoma--a clinical, histologic and immunohistochemical study.
    Akrish S; Ben-Izhak O; Sabo E; Rachmiel A
    Oral Surg Oral Med Oral Pathol Oral Radiol; 2015 Mar; 119(3):318-25. PubMed ID: 25547823
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Oral proliferative verrucous leukoplakia (PVL); open trial of surgery compared with combined therapy using surgery and methisoprinol in papillomavirus-related PVL.
    Femiano F; Gombos F; Scully C
    Int J Oral Maxillofac Surg; 2001 Aug; 30(4):318-22. PubMed ID: 11518355
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Spindle-cell carcinoma of the oral cavity.
    Takagi M; Ishikawa G
    Bull Tokyo Med Dent Univ; 1982 Dec; 29(4):103-11. PubMed ID: 6959736
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Carcinoma and dysplasia in oral leukoplakias in Taiwan: prevalence and risk factors.
    Lee JJ; Hung HC; Cheng SJ; Chen YJ; Chiang CP; Liu BY; Jeng JH; Chang HH; Kuo YS; Lan WH; Kok SH
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2006 Apr; 101(4):472-80. PubMed ID: 16545712
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Oral medicine case book 37. Proliferative verrucous leukoplakia.
    Padayachee S; Peck MT; Dreyer WP; Allie A; Afrogheh A
    SADJ; 2012 Mar; 67(2):78-80. PubMed ID: 23189896
    [No Abstract]   [Full Text] [Related]  

  • 32. Proliferative verrucous leukoplakia: a report of ten cases.
    Zakrzewska JM; Lopes V; Speight P; Hopper C
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 1996 Oct; 82(4):396-401. PubMed ID: 8899776
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Oral verrucous hyperplasia: histologic classification, prognosis, and clinical implications.
    Wang YP; Chen HM; Kuo RC; Yu CH; Sun A; Liu BY; Kuo YS; Chiang CP
    J Oral Pathol Med; 2009 Sep; 38(8):651-6. PubMed ID: 19656267
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Two cases of malignant progression of oral leukoplakia.
    Hayashi N; Okamura H; Honda T; Komoto K
    Fukuoka Shika Daigaku Gakkai Zasshi; 1987; 13(4):221-8. PubMed ID: 3505212
    [No Abstract]   [Full Text] [Related]  

  • 35. Oral lesions with a papillary surface texture: clinical and pathological correlations.
    Firth NA
    Ann R Australas Coll Dent Surg; 2000 Oct; 15():111-5. PubMed ID: 11709915
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Proliferative verrucous leukoplakia. Four cases with flow cytometric analysis.
    Kahn MA; Dockter ME; Hermann-Petrin JM
    Oral Surg Oral Med Oral Pathol; 1994 Oct; 78(4):469-75. PubMed ID: 7800379
    [TBL] [Abstract][Full Text] [Related]  

  • 37. High incidence of DNA ploidy abnormalities and increased Mcm2 expression may predict malignant change in oral proliferative verrucous leukoplakia.
    Gouvêa AF; Santos Silva AR; Speight PM; Hunter K; Carlos R; Vargas PA; de Almeida OP; Lopes MA
    Histopathology; 2013 Mar; 62(4):551-62. PubMed ID: 23347057
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Proliferative verrucous leukoplakia: a case report of multiple metachronous oral verrucous carcinoma.
    Lombardi N; Varoni EM; Franchini R; Lodi G
    BMJ Case Rep; 2023 Nov; 16(11):. PubMed ID: 37967933
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Retrospective case-control study of viral pathogen screening in proliferative verrucous leukoplakia lesions.
    García-López R; Moya A; Bagan JV; Pérez-Brocal V
    Clin Otolaryngol; 2014 Oct; 39(5):272-80. PubMed ID: 25099922
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinicopathological features and immunohistochemical expression of p53, Ki-67, Mcm-2 and Mcm-5 in proliferative verrucous leukoplakia.
    Gouvêa AF; Vargas PA; Coletta RD; Jorge J; Lopes MA
    J Oral Pathol Med; 2010 Jul; 39(6):447-52. PubMed ID: 20412398
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 28.